RN7SL197P

Across TCGA pan-cancer cohorts, RN7SL197P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL197P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RN7SL197P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL197P expression acts as an unfavorable survival marker, although some lineages such as LAML and UCS show a favorable association.

READ, LAML, and UCS are the cancer types where RN7SL197P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.584	0.831	.001	63	view →
LAML	DFS	Tertile	All	0.623	0.307	.013	30	view →
UCS	OS	Tertile	IV	1.000	0.276	.018	18	view →
SKCM	OS	Tertile	IV	0.274	0.668	.014	15	view →
CESC	OS	Tertile	All	0.855	0.554	.027	12	view →
THYM	DFS	Tertile	All	0.594	0.931	.012	9	view →
LIHC	DFS	Tertile	All	0.362	0.549	.038	9	view →
SARC	OS	Tertile	All	0.173	0.514	.020	6	view →
STAD	DFS	Quartile	IV	0.268	0.546	.040	3	view →
HNSC	OS	Tertile	All	0.364	0.614	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL197P–READ (DFS)

Open the READ breakdown →